The big takeaway is simple.
E-cigarettes with nicotine help people quit smoking better than patches. Or gum. Or lozenges. Even better than behavioral coaching, mostly.
This isn’t a new whisper in the hallway. It’s the result of a major review looking at global research. A team at Oxford combined data from fourteen systematic reviews spanning 2014 to 2023. They wanted to see what actually works.
The Stronger Data Points One Way
Here’s the catch. Quality matters.
When the researchers looked only at the highest-quality studies—the reliable ones—the picture got sharper. Nicotine vapes consistently beat Nicotine Replacement Therapy (NRT). They beat non-nicotine e-cigarettes too. The lower-quality reviews were messier, less precise. But when you stick to the best evidence? Vapes win.
It’s not even close.
What We Don’t Know
Still, holes in the map exist.
The researchers built an “Evidence and Gap Map” to see where science is missing the mark. Right now, there’s nothing high-quality comparing nicotine e-cigarettes to cytisine. Or bupropion. Or nicotine pouches. Nothing solid.
Varenicline? Same issue. Only one small study exists, and it’s considered high-risk for bias. That’s thin. Very thin.
Safety and the Global Gap
And then there’s safety.
Do e-cigarettes cause serious long-term harm? The evidence is inconclusive. We don’t really know yet. Most of the data also comes from wealthy, high-income countries. Low- and middle-income nations are barely on the radar for this specific kind of cessation research.
Future studies need to track adverse events better. And they need to go somewhere other than the Global North.
“The evidence is clear and consistent… e-cigarettes are effective at helping people to stop smoking.”
— Dr. Angela Difeng Wu
The Consensus
Lead author Dr. Angela Difeng W from Oxford thinks this map should end the “mixed evidence” arguments once and for all. According to the meta-analyses they consulted, the signal is consistent. Vapes help people quit.
Funded by Cancer Research UK and published in Addiction (March 2026), the study closes some doors but leaves others slightly ajar.
We know they work better than patches. We still don’t fully know if they’re safe ten years down the line.
